文献リスト

1）Osada H, Takahashi T. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis. 2007; 28(1): 2-12

2）Kosaka N, Iguchi H, Ochiya T. Circulating micro­RNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010; 101(10): 2087-92

3）Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6): 654-9

4）Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor.Cell. 1983; 33: 967-77

5）Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multi­vesicular endosomes. Science. 2008; 319(5867): 1244-7

6）Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A. 2010; 107(14): 6328-33

7）Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell mig­ration. Mol Cell. 2010; 39(1): 133-44

8）Kosaka N, Iguchi H, Yoshioka Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010; 285(23): 17442-52

9）Hood JL, San RS, Wickline SA. Exosomes released by melanoma cells preparesentinel lymph nodes for tumor metastasis. Cancer Res. 2011; 71(11): 3792-801

10）Taylor DD, Gercel-Taylor C. Exosomes/microve­sicles: mediators of cancer-associated immuno­suppressive microenvironments. Semin Immuno­pathol. 2011; 33(5): 441-54

11）Thery C, Ostrowski M, Segura E. Membrane­vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9(8): 581-93

12）Denzer K, van Eijk M, Kleijmeer MJ, et al. Follicular dendritic cells carry MHC class II-expre­ssing microvesicles at their surface. J Immunol. 2000; 165(3): 1259-65

13）Admyre C, Grunewald J, Thyberg J, et al. Exo­somes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J. 2003; 22(4): 578-83

14）Prado N, Marazuela EG, Segura E, et al. Exo­somes from bronchoalveolar fluid of tolerized mice prevent allergic reaction. J Immunol. 2008; 181(2): 1519-25

15）Qazi KR, Torregrosa Paredes P, Dahlberg B, et al. Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis.Thorax. 2010; 65(11): 1016-24

16）Andre F, Schartz NE, Movassagh M, et al. Malig­nant effusions and immunogenic tumour-derived exosomes. Lancet. 2002; 360(9329): 295-305

17）Poutsiaka DD, Schroder EW, Taylor DD, et al. Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia anti­gen by macrophages. J Immunol. 1985; 134(1): 138-44

18）Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998; 4(5): 594-600

19）Morse MA, Garst J, Osada T, et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med. 2005; 3(1): 9

20）Viaud S, Thery C, Ploix S, et al. Dendritic cell-derived exosomes for cancer immunotherapy: what’s next? Cancer Res. 2010; 70(4): 1281-5

21）Bard MP, Hegmans JP, Hemmes A, et al. Proteo­micanalysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol. 2004; 31(1): 114-21

22）Hegmans JP, Bard MP, Hemmes A, et al. Proteo­micanalysis of exosomes secreted by human mesothelioma cells. Am J Pathol. 2004; 164(5): 1807-15

23）Li Y, Zhang Y, Qiu F, et al. Proteomic identifi­cation of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis. 2011; 32(15): 1976-83

24）Raimondo F, Morosi L, Chinello C, et al. Advances in membranous vesicle and exosome proteomics improving biological understanding and bio­marker discovery. Proteomics. 2011; 11(4): 709-20

25）Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008; 18(10): 997-1006

26）Hu Z, Chen X, Zhao Y, et al. Serum microRNA signatures identified in a genome-wide serum­microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010; 28(10): 1721-6

27）Rabinowits G, Gerçel-Taylor C, Day JM, et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009; 10(1): 42-6

28）Boeri M, Verri C, Conte D, et al. MicroRNA­signatures in tissues and plasma predict develop­ment and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A. 2011; 108(9): 3713-8

29）Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic bio­markers of ovarian cancer. Gynecol Oncol. 2008; 110(1): 13-21

30）Hector Peinado, Maša Alečković, Simon Lavotshkin, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18(6): 883-91

31）Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011; 29(4): 341-5

32）Ciravolo V, Huber V, Ghedini GC, et al. Potential­role of HER2-overexpressing exosomes in coun­tering trastuzumab-based therapy. J Cell Physiol. 2012; 227(2): 658-67

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp